跳至主要内容
临床试验/CTRI/2024/12/077601
CTRI/2024/12/077601尚未招募不适用

Efficacy and safety of microneedling in the management of atrophic acne scars

Institute of Medical Science, Banaras Hindu University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年12月13日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Qualitative Goodman Baron scores, Quantitative Goodman Baron scores, % improvement by patient assessment

研究概览

简要总结

Patients with acne scar aged 18-40 years seeking treatment and providing consent will be included in study after ruling out exclusion criteria. The patients will undergo microneedling in 4 sessions at 4 weekly intervals and response will be assessed while looking out for adverse effects

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • All patients aged between 18- 40 years with atrophic acne scars voluntarily seeking treatment at I.M.S., B.H.U., Varanasi
  • Absence of active lesions of acne while on or off treatment.
  • Informed consent.

排除标准

  • Pregnant and lactating women
  • Active lesions on treatment
  • Keloidal tendencies
  • Collagen vascular diseases
  • Bleeding disorders
  • Anticoagulant treatment
  • Active bacterial, fungal or viral infection over face
  • Any invasive acne scar treatment performed in the last 3 months.
  • History of photosensitivity
  • History of intake of oral isotretinoin, oral corticosteroids in the preceding 3 months
  • History of use of topical corticosteroids in the preceding 2 weeks.

结局指标

主要结局

Qualitative Goodman Baron scores, Quantitative Goodman Baron scores, % improvement by patient assessment

时间窗: baseline, 2 weeks, 6 weeks, 10 weeks, 14 weeks, 18 weeks

次要结局

  • adverse effects(baseline, 2 weeks, 6 weeks, 10 weeks, 14 weeks, 18 weeks)

研究者

发起方
Institute of Medical Science, Banaras Hindu University
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Nilanjana Debnath

Institute of Medical Sciences, Banaras Hindu University

研究点 (1)

Loading locations...

相似试验